Atara Biotherapeutics, Inc.
ATRA
$15.63
$1.6511.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.75% | -70.07% | -17.84% | -34.39% | -77.03% |
| Total Receivables | -- | -75.37% | -95.65% | 137.12% | 167.03% |
| Inventory | -- | -- | 9.78% | 112.11% | 138.51% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.82% | -44.71% | 62.10% | 2.38% | -39.99% |
| Total Current Assets | -60.31% | -74.46% | -36.30% | -22.61% | -63.78% |
|
|
|||||
| Total Current Assets | -60.31% | -74.46% | -36.30% | -22.61% | -63.78% |
| Net Property, Plant & Equipment | -78.15% | -41.76% | -30.09% | -25.56% | -24.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -74.31% | -26.47% | -35.94% | -46.62% | -45.11% |
| Total Assets | -68.54% | -62.46% | -34.08% | -24.41% | -52.41% |
|
|
|||||
| Total Accounts Payable | -66.46% | -51.51% | 18.54% | -67.04% | 26.95% |
| Total Accrued Expenses | -58.23% | -59.14% | -56.32% | -52.11% | -52.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -83.98% | -0.83% | 14.27% | 10.24% | 8.07% |
| Total Finance Division Other Current Liabilities | -98.51% | -87.02% | 22.17% | 902.02% | 800.34% |
| Total Other Current Liabilities | -98.51% | -87.02% | 22.17% | 902.02% | 800.34% |
| Total Current Liabilities | -90.18% | -73.49% | -5.38% | 97.22% | 98.88% |
|
|
|||||
| Total Current Liabilities | -90.18% | -73.49% | -5.38% | 97.22% | 98.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -60.14% | -33.58% | -31.03% | -27.35% | -25.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.87% | 1.23% | -47.55% | -62.49% | -63.45% |
| Total Liabilities | -68.47% | -55.57% | -22.04% | -2.66% | -4.53% |
|
|
|||||
| Common Stock & APIC | 3.67% | 3.09% | 4.66% | 5.00% | 3.35% |
| Retained Earnings | 0.29% | -0.78% | -4.34% | -6.98% | -9.85% |
| Treasury Stock & Other | -- | -- | 103.92% | 103.85% | 98.50% |
| Total Common Equity | 68.39% | 43.98% | 1.96% | -78.09% | -1,587.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.39% | 43.98% | 1.96% | -78.09% | -1,587.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 68.39% | 43.98% | 1.96% | -78.09% | -1,587.36% |
|
|
|||||